These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 6282190
21. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams]. Jarlier V, Bismuth R, Grosset J. Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393 [Abstract] [Full Text] [Related]
22. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae. Kawakami Y, Okimura Y, Horiuchi N, Kanai M. Microbiol Immunol; 1982 May; 26(7):617-21. PubMed ID: 6290854 [No Abstract] [Full Text] [Related]
23. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci. Cynamon MH, Granato PA. Chemotherapy; 1982 May; 28(3):204-8. PubMed ID: 6212205 [Abstract] [Full Text] [Related]
24. Ceftriaxone--and more to come. Marks MI. J Pediatr; 1983 Jul; 103(1):70-2. PubMed ID: 6306195 [No Abstract] [Full Text] [Related]
25. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics]. Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T. Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368 [Abstract] [Full Text] [Related]
30. New concepts in the management of infants and children with meningitis. McCracken GH. Pediatr Infect Dis; 1983 Feb; 2(3 Suppl):S51-5. PubMed ID: 6306611 [No Abstract] [Full Text] [Related]
33. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics]. Matsuo K, Uete T. Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908 [Abstract] [Full Text] [Related]
34. The cephalosporin compounds in severe neonatal infection. Schaad UB. Eur J Pediatr; 1984 Jan; 141(3):143-6. PubMed ID: 6321189 [Abstract] [Full Text] [Related]
35. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon]. Baumgärtner M, Grehn M, Wundt W. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564 [Abstract] [Full Text] [Related]
36. Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals. Klesel N, Limbert M, Schrinner E, Seeger K, Seibert G, Winkler I. Infection; 1984 Jun; 12(4):286-92. PubMed ID: 6092278 [Abstract] [Full Text] [Related]
37. Antimicrobial activity of cefmetazole compared with those of other cephalosporins. Schell RF, Kurzynski TA, Le Frock JL, Donato JB. Chemotherapy; 1986 Jun; 32(5):431-8. PubMed ID: 3463448 [Abstract] [Full Text] [Related]
38. New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila. Toro J, Sawatari K, Kanda T, Saito A, Hara K. Microbiol Immunol; 1983 Jun; 27(8):649-54. PubMed ID: 6316115 [Abstract] [Full Text] [Related]
40. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime. Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S. Drugs Exp Clin Res; 1989 Jun; 15(1):1-10. PubMed ID: 2663406 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]